TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Genmab, Pfizer’s tisotumab vedotin takes a leap towards EU approval for cervical cancer In a significant development for cervical cancer treatment, Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have… byPallavi MadhirajuFebruary 5, 2024